Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
Viktor Fleming, Xiaoying Hu, Rebekka Weber, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 400

Showing 1-25 of 400 citing articles:

The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw, Lalita A. Shevde
Cancer Research (2019) Vol. 79, Iss. 18, pp. 4557-4566
Open Access | Times Cited: 2541
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1423
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1199
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
Christopher Groth, Xiaoying Hu, Rebekka Weber, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 16-25
Open Access | Times Cited: 663
Neutrophils as emerging therapeutic targets
Tamás Németh, Markus Sperandio, Attila Mócsai
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 4, pp. 253-275
Closed Access | Times Cited: 540
MDSC: Markers, development, states, and unaddressed complexity
Samarth Hegde, Andrew M. Leader, Miriam Mérad
Immunity (2021) Vol. 54, Iss. 5, pp. 875-884
Open Access | Times Cited: 460
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Andrew M. K. Law, Fátima Valdés‐Mora, David Gallego‐Ortega
Cells (2020) Vol. 9, Iss. 3, pp. 561-561
Open Access | Times Cited: 379
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
Irena Kaplanov, Yaron Carmi, Rachel Kornetsky, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 4, pp. 1361-1369
Open Access | Times Cited: 370
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Paola De Cicco, Giuseppe Ercolano, Angela Ianaro
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 257
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
Yuhui Yang, Chunyan Li, Tao Liu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 203
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma
Handan Xiang, Carlo P. Ramil, Josephine Hai, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 4, pp. 436-450
Open Access | Times Cited: 193
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Matthew Dysthe, Robin Parihar
Advances in experimental medicine and biology (2020), pp. 117-140
Closed Access | Times Cited: 189
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayık, Yadi Zhou, Chihyun Park, et al.
Cancer Discovery (2020) Vol. 10, Iss. 8, pp. 1210-1225
Open Access | Times Cited: 185
Myeloid-Derived Suppressor Cells in Sepsis
Irene T. Schrijver, Charlotte Théroude, Thierry Roger
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 184
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
Chenhao Zhou, Zewen Kelvin Tuong, Ian H. Frazer
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 182
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
Sherly Mardiana, Saar Gill
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 182
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
Antonino Bruno, Lorenzo Mortara, Denisa Baci, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 181
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108597-108597
Open Access | Times Cited: 180
HPV post-infection microenvironment and cervical cancer
Yi Yuan, Xushan Cai, Fangrong Shen, et al.
Cancer Letters (2020) Vol. 497, pp. 243-254
Closed Access | Times Cited: 168
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states
Hanbing Song, H Weinstein, Paul Allegakoen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 155
The multifaceted immune regulation of bladder cancer
Anna K. Schneider, Mathieu F. Chevalier, Laurent Derré
Nature Reviews Urology (2019) Vol. 16, Iss. 10, pp. 613-630
Closed Access | Times Cited: 154
Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment
Kerri‐Ann Norton, Chang Gong, Samira Jamalian, et al.
Processes (2019) Vol. 7, Iss. 1, pp. 37-37
Open Access | Times Cited: 151
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
Luca Cassetta, Kirsten Bruderek, Joanna Skrzeczyńska-Moncznik, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001223-e001223
Open Access | Times Cited: 150
Tumor immune microenvironment in head and neck cancers
Samantha M. Y. Chen, Alexandra L. Krinsky, Rachel A. Woolaver, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 7, pp. 766-774
Open Access | Times Cited: 139
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3845-3858
Open Access | Times Cited: 132
Page 1 - Next Page

Scroll to top